1. Home
  2. PLSE vs ARCB Comparison

PLSE vs ARCB Comparison

Compare PLSE & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • ARCB
  • Stock Information
  • Founded
  • PLSE 2014
  • ARCB 1923
  • Country
  • PLSE United States
  • ARCB United States
  • Employees
  • PLSE N/A
  • ARCB N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • ARCB Trucking Freight/Courier Services
  • Sector
  • PLSE Health Care
  • ARCB Industrials
  • Exchange
  • PLSE Nasdaq
  • ARCB Nasdaq
  • Market Cap
  • PLSE 1.3B
  • ARCB 1.4B
  • IPO Year
  • PLSE 2016
  • ARCB N/A
  • Fundamental
  • Price
  • PLSE $16.84
  • ARCB $61.28
  • Analyst Decision
  • PLSE
  • ARCB Buy
  • Analyst Count
  • PLSE 0
  • ARCB 13
  • Target Price
  • PLSE N/A
  • ARCB $92.25
  • AVG Volume (30 Days)
  • PLSE 163.1K
  • ARCB 442.9K
  • Earning Date
  • PLSE 05-08-2025
  • ARCB 04-29-2025
  • Dividend Yield
  • PLSE N/A
  • ARCB 0.77%
  • EPS Growth
  • PLSE N/A
  • ARCB 50.16
  • EPS
  • PLSE N/A
  • ARCB 7.55
  • Revenue
  • PLSE N/A
  • ARCB $4,109,676,999.00
  • Revenue This Year
  • PLSE N/A
  • ARCB $3.83
  • Revenue Next Year
  • PLSE N/A
  • ARCB $7.17
  • P/E Ratio
  • PLSE N/A
  • ARCB $7.81
  • Revenue Growth
  • PLSE N/A
  • ARCB N/A
  • 52 Week Low
  • PLSE $6.66
  • ARCB $55.19
  • 52 Week High
  • PLSE $25.00
  • ARCB $129.83
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 49.42
  • ARCB 48.38
  • Support Level
  • PLSE $15.92
  • ARCB $58.16
  • Resistance Level
  • PLSE $17.54
  • ARCB $63.60
  • Average True Range (ATR)
  • PLSE 0.90
  • ARCB 3.13
  • MACD
  • PLSE -0.09
  • ARCB 0.83
  • Stochastic Oscillator
  • PLSE 29.65
  • ARCB 60.26

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About ARCB ArcBest Corporation

ArcBest Corp is engaged in logistics operations. The company operates in two operating segments, The Asset-Based segment includes the results of operations of ABF Freight System, Inc. and certain other subsidiaries. The segment operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed LTL services. The services including freight transportation related to managed transportation solutions and other services. The Asset-Light segment includes the results of operations of the Company's service offerings in truckload, ground expedite, dedicated, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

Share on Social Networks: